Plain-English translation of NCT07554560 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a medical food called Encala that's designed to help your body absorb fats more easily — a common problem for people with pancreatic cancer. The medication is specially formulated so your body doesn't need your pancreas to work as hard to process fats. Researchers want to see if this treatment is easy to use, well-tolerated, safe, and actually helps with nutrition and digestive symptoms.
Many people with pancreatic cancer struggle to absorb fats properly, which leads to digestive problems, weight loss, and feeling weaker. This study exists because current treatments don't always address this gap, and doctors hope this medication can offer real nutritional support when patients need it most.
You likely qualify if…
You likely don't qualify if…
You would take the medical food 4 to 5 times daily for 8 weeks, mixing it into foods, drinks, or feeding formulas however works best for you — adding about 400 to 500 calories per day. You'd visit the research center at the start, after 4 weeks, and after 8 weeks for check-ins that include blood tests, measurements of your weight and strength, and questions about how you're feeling and digesting food.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States